MALAT1 and breast cancer: Subcutaneous injection of MALAT1 antisense oligonucleotides could effectively downregulate the MALAT1 expression in the tumor site and result in a formation of cystic and poorly metastasizing tumors in the luminal B breast cancer mouse model [31].